-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $83 at BofA Securities
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $75 at JPMorgan on Favorable Near-Term Outlook
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $96 at Citizens: Still Top Pick Ahead of ACACIA-HCM
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $90 at Jefferies
-
-
-
-
-
-
-
Cytokinetics (CYTK) halted, news pending
-
-
-
-
-
-
-
Cytokinetics presents additional MAPLE-HCM trial data at medical conferences
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
-
408,180 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

